NeuroSense Therapeutics NRSN
NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Profit After Tax Growth (3y) (2024)

Analysis

NeuroSense Therapeutics (NRSN) Profit After Tax Growth (3y) (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 19.87%
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn -129.22%
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 6.30%
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 10.23%
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn 17.25%
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn 91.31%
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 37.44%
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn -45.23%
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn -
10 NeuroSense Therapeutics 8.09 Mn 7.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -31.07%
API Access

NeuroSense Therapeutics Profit After Tax Growth (3y) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax-growth-3y&ticker=NRSN&period=max&api_key=YOUR_API_KEY